Filter Results:
(45)
Show Results For
- All HBS Web
(165)
- News (45)
- Research (98)
- Events (1)
- Multimedia (1)
- Faculty Publications (61)
Show Results For
- All HBS Web
(165)
- News (45)
- Research (98)
- Events (1)
- Multimedia (1)
- Faculty Publications (61)
Page 1 of 45
Results →
Sort by
- 18 Feb 2016
- News
Challenge Aims to Speed Drug Trials Process
clinical trials process. Today, it takes at least 10 years and billions of dollars for one FDA-approved drug to move from research labs to medicine cabinets. Precision medicine will bring faster innovation,... View Details
- 09 Nov 2011
- News
Resistance Is Futile
- 01 Oct 2011
- News
Resistance Is Futile
- 07 Feb 2024
- News
The Sound of Success
A groundbreaking gene therapy developed by Akouos, Inc., a precision genetic medicine company founded in 2016 by Emmanuel (Manny) Simons (MBA 2012), has enabled an 11-year-old boy from Morocco to hear sounds for the first time. According to a recent New York Times... View Details
- 04 Apr 2024
- News
The Making of a Medical Milestone
How did Eledon get involved with the transplant case at MGH? We have multiple trials going on around the world, including at MGH. We have the most advanced novel drug in clinical development for transplant... View Details
Keywords: Margie Kelley
- 01 Dec 2023
- News
Wide Horizon
There were three critical events that led John Rodakis (MBA 1997) to form the nonprofit N of One in 2014 and ultimately dedicate his life to surfacing breakthrough autism research. The first occurred on Thanksgiving of 2012. He had driven about four hours with his wife... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details
- 31 May 2023
- News
Alumni Achievement Awards 2023
came to Vertex in 2017, there was a medicine finishing early clinical trials with the potential to serve up to 90 percent of patients with cystic fibrosis (CF). In October 2019 that became Trikafta. Now CF patients talk to me about... View Details
- 01 Jun 2023
- News
Research Brief: The Best Medicine
the clinical approval process. In a survey experiment, the researchers found that 72 percent of doctors had been asked by their patients whether a new drug would “work in people like me.” Black patients and the doctors who treat them put... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
molecules responsible for transporting DNA code from a cell's nucleus to the ribosomes that create proteins. mRNA Therapeutics, as the company calls this new drug application, gives patients' cells the code they need to begin creating... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical View Details
- 24 Sep 2020
- News
The Race for a Vaccine
Pisano says. But vaccines don’t really fit the same business model as high-volume therapeutic drugs; they have an even higher bar for safety and effectiveness, because unlike most other drugs they are administered to healthy populations.... View Details
- 15 Dec 2024
- News
After Ozempic
affiliate in Plainsboro, New Jersey. That all changed when its breakthrough drug for type 2 diabetes, Ozempic, hit the market in 2018. By some biochemical mystery, it also turned out to be a powerful tool for weight loss—which led to the... View Details
- 01 Jun 2018
- News
Floor It
case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 01 Dec 2013
- News
Your Own Medicine
says. "That's just unheard of." If all goes well, the next move could be trials for FDA approval. And HT-100 is just one of the drugs that DART is involved in. It is funding a cardiac View Details